Biomat USA

Name

Biomat USA

Legal name

Biomat USA, Inc.

Website

https://grifolsplasma.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Plasma Collection Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Plasma Fractionation & Purification Manufacturing (HLAIAHAI)

Keywords

• Plasma collection services
• Blood plasma donation
• Plasmapheresis services
• Plasma donor compensation
• Specialty plasma programs

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Plasma Collection Services: Biomat USA operates plasma donation centers that collect plasma from donors. The collected plasma is used by Grifols to manufacture plasma-derived medicines. Revenue is generated through the value of plasma collected and processed for biopharmaceutical manufacturing.
2. Plasma-Derived Medicines Manufacturing: Grifols manufactures plasma medicines including treatments for hemophilia, Alpha-1 Antitrypsin Deficiency, primary immunodeficiency diseases, and other conditions. The company operates manufacturing facilities and sells finished pharmaceutical products globally.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Biomat USA operates a network of plasma donation centers in the United States as a subsidiary of Grifols. Healthy adult donors visit these centers to donate plasma through plasmapheresis, a process that separates plasma from other blood components and returns the cells to the donor. Donors are compensated via prepaid debit card, and the collected plasma is supplied to Grifols for manufacturing plasma-derived medicines used to treat hemophilia, Alpha-1 Antitrypsin Deficiency, primary immunodeficiency, and other conditions.

Product overview

Biomat USA, a subsidiary of Grifols, operates the Grifols Plasma network of plasma donation centers — the world's most diversified plasma collection network with over 400 centers. The core offering centers on plasma collection services, supplemented by the DonorHub™ digital platform for donor management. Specialty Plasma Programs offer enhanced compensation for donors with specific antibodies. The Refer a Friend Program drives donor acquisition through incentives. Grifols Plasma Promo Alerts enables SMS-based donor communication. All donors receive compensation via a pre-paid debit card system.

Differentiator

Problem solved

Functional benefit

Products and services

• Grifols Plasma Donation Centers Physical plasma donation centers where healthy adult donors (18-69 years old, at least 110 lbs) can donate plasma via plasmapheresis. The collected plasma is supplied to Grifols for manufacturing plasma-derived medicines. Donors are compensated via prepaid debit card. The network is part of Grifols' 400+ center global collection network.
• DonorHub Mobile and web application that allows plasma donors to manage appointments, check in, view estimated wait times, track donation history and compensation, and access referral codes for the Refer a Friend program. Available on iOS and Android.
• Specialty Plasma Programs Targeted plasma donation programs for donors with specific antibodies, including Anti-Hepatitis B, Anti-D (Rho(D)), Anti-Tetanus, Anti-Rabies, Anti-RSV, and Male AB Programs. Donors receive additional compensation and supply plasma for targeted immunoglobulin products.
• Refer a Friend Program Referral program allowing existing donors to invite friends to become plasma donors. Referrers receive a $100 USD bonus per valid referral once the referred friend registers with their code via DonorHub and completes two donations.

Quantifiable outcome

• 1,200 milliliters of plasma collected per donation
• +5 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• USO (United Service Organizations)minorStrategic or Co-development PartnerGrifols is a long-time partner of USO, supporting men and women serving in the U.S. military and their families. Many Grifols employees and donors are active military or veterans.
• Habitat for HumanityminorStrategic or Co-development PartnerGrifols collaborates with Habitat for Humanity locally and nationally. Employees have participated in multiple house and playground builds. The J.A. Grifols Foundation has supported Habitat affiliates with community improvement grants.
• Feeding AmericaminorStrategic or Co-development PartnerGrifols supports Feeding America nationally to fight hunger. Through the Box Out Hunger food drive, Grifols has donated close to 2.7 million pounds of food to local communities over 5 years. Food bank drop-off locations are created at Grifols donor centers.
• Plasma Protein Therapeutics Association (PPTA)coreStrategic or Co-development PartnerPPTA is the industry association for plasma protein therapeutics. Grifols collaborates through PPTA's Pathogen Safety Steering Committee. PPTA launched International Plasma Awareness Week (IPAW) in 2013.
• National Organization for Rare Disorders (NORD)minorStrategic or Co-development PartnerThe J.A. Grifols Foundation and NORD established the Plasma Donor Emergency Relief Program (PDER) to provide non-medical financial assistance to eligible plasma donors. The program is currently being piloted at 6 U.S. Grifols plasma centers.
• J.A. Grifols Lucas FoundationcoreStrategic or Co-development PartnerThe Jose Antonio Grifols Lucas Foundation provides support to communities where plasma donors are valued. It awards quarterly community enhancement grants for civic, social, or educational programs addressing community needs where Grifols plasma centers exist.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kedrion Biopharma: Global plasma fractionator with U.S. plasma collection operations, collecting source plasma for its own therapies; overlaps with Biomat USA on both the collection and fractionation side of the value chain.
• CSL Plasma: U.S. plasma collection subsidiary of CSL Behring, operating a large network of paid plasma donation centers; the closest direct competitor to Biomat USA in the U.S. source-plasma market.
• Octapharma Plasma: U.S. plasma collection business of Octapharma AG, running a sizable chain of paid plasma donation centers; competes head-to-head with Biomat USA for donors in overlapping U.S. geographies.
• BioLife Plasma Services: Plasma collection subsidiary of Takeda, operating hundreds of U.S. paid plasma donation centers; directly comparable to Biomat USA in donor compensation, center model, and downstream fractionation use.
• BPL Plasma: U.S. plasma collection arm of Bio Products Laboratory, operating a network of paid plasma donation centers; directly competes with Biomat USA for U.S. source plasma.

Emerging players

• ADMA Biologics: U.S. specialty immune globulin manufacturer building out its own plasma collection footprint (ADMA BioCenters); partial overlap with Biomat USA — a smaller but growing collector in the same value chain.

Regional players

• American Red Cross: Large U.S. nonprofit blood and plasma collector; comparable activities in source-material collection but operates on a volunteer, non-compensated model and therefore does not compete directly for paid donors.
• Sanquin Plasma Products: Dutch nonprofit blood and plasma collector with growing paid plasma programs in Europe and the U.S.; comparable collection activity to Biomat USA but with a primary European footprint and non-compensated legacy model.

Broad incumbents

• Takeda Pharmaceutical Company: Parent of BioLife Plasma Services; a global biopharmaceutical major whose plasma-derived therapy franchise is directly dependent on the same U.S. source plasma supply chain that Biomat USA feeds into Grifols.
• CSL Behring: Parent of CSL Plasma and one of the world's largest plasma fractionators; competes with Grifols (and therefore Biomat USA) end-to-end across plasma collection and plasma-derived therapeutics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomat USA